288.1 ð é«åžçç
288.1.0.1 ð äžé éé»
288.1.0.1.1 Atrial Septal Defect (ASD)
288.1.0.1.1.1 Types (Anatomic Locations)
- Ostium secundum (70%): middle of septum (foramen ovale region) â most common; closes via percutaneous device
- Ostium primum (15-20%): low septum near AV valves (partial AVSD); requires surgical repair; associated with mitral cleft
- Sinus venosus (5-10%): near SVC or IVC entry; often with anomalous pulmonary venous return; surgical
- Coronary sinus (< 1%): unroofed coronary sinus; rare
288.1.0.1.1.2 Pathophysiology
- LâR shunt at atrial level (LA â RA via defect)
- Volume overload of RA + RV â RA/RV dilation
- â pulmonary blood flow â eventual pulmonary HTN (slower than VSD/PDA)
- AF common in adults (LA + RA dilation)
- Eisenmenger uncommon (only ~ 10% of unrepaired large ASD)
288.1.0.1.1.3 Clinical Presentation
- Asymptomatic through childhood and young adulthood
- 3rd-4th decade onset of symptoms: dyspnea, fatigue, palpitations
- AF common adult presentation
- Paradoxical embolism / stroke
- Recurrent pulmonary infections
288.1.0.1.1.4 Examination
- Fixed split S2 (classic â S2 doesnât vary with respiration)
- Soft systolic ejection murmur at L upper sternal border (relative pulmonic stenosis from â flow)
- Mid-diastolic rumble at L lower sternal border (relative tricuspid stenosis from â flow)
- RV heave
- Loud P2 if PH
288.1.0.1.1.5 ECG
- Right axis deviation
- Incomplete RBBB (typical secundum)
- Left axis deviation + first-degree AV block (ostium primum)
- RAE, RVH (advanced)
- AF (adults)
288.1.0.1.1.6 CXR
- Cardiomegaly (RA + RV)
- Increased pulmonary vasculature (shunt vascularity)
- âSnowmanâ sign (TAPVR â total anomalous pulmonary venous return)
288.1.0.1.1.7 Echo
- Defect visualization (2D + color Doppler)
- Bubble study (agitated saline): RA bubbles â LA (RâL flow with Valsalva release)
- Pulmonary HTN assessment
- RV function
288.1.0.1.1.8 TEE
- Definitive for ASD type, size, surrounding structures
- Critical for percutaneous closure planning
288.1.0.1.1.9 Treatment
Closure Indications - Hemodynamically significant ASD: RA/RV dilation, Qp:Qs > 1.5:1 - Paradoxical embolism (cryptogenic stroke) - Exercise intolerance - Pulmonary HTN (early/moderate, not Eisenmenger) - AF - Decompensated HF (controversial)
Closure Contraindications - Eisenmenger syndrome (PVR > SVR, RâL shunt) â absolute - Severe pulmonary HTN with reactive vasculature debatable
Methods - Percutaneous device closure (Amplatzer septal occluder) â first-line for ostium secundum - Surgical closure for ostium primum, sinus venosus, coronary sinus, or complex anatomy - AC + DAPT for 6 months post-percutaneous
288.1.0.1.2 Ventricular Septal Defect (VSD)
288.1.0.1.2.1 Types
- Perimembranous (80%): most common; in membranous septum
- Muscular (5-20%): in muscular septum; often multiple
- Inlet (5%): AV canal type (AVSD)
- Outlet (subaortic, supracristal, 5%): high; AR risk
- Doubly committed subarterial (Asian populations)
288.1.0.1.2.2 Pathophysiology
- LâR shunt at ventricular level (LV â RV via defect)
- Magnitude depends on defect size + PVR
- Small (restrictive): high gradient, small shunt â minimal hemodynamic consequence
- Moderate-large: significant shunt â LV volume overload â HF, PH
- Most VSDs close spontaneously in childhood (75% by 10 yo, especially small muscular)
- Adult unrepaired large VSD â Eisenmenger common
288.1.0.1.2.3 Clinical Presentation
- Small VSD: asymptomatic (Rogerâs murmur)
- Moderate-large: HF symptoms, exercise intolerance
- Adult unrepaired: Eisenmenger (cyanosis, polycythemia)
288.1.0.1.2.4 Examination
- Holosystolic harsh murmur at L lower sternal border (3rd-4th ICS)
- Thrill (large defect)
- Loud P2 if PH
- S3, signs of HF
288.1.0.1.2.6 Echo
- Defect visualization, size, location
- Doppler gradient
- LV/LA size, function
- PH assessment
- Aortic regurgitation (associated with subaortic VSD)
288.1.0.1.2.7 Treatment
Closure Indications - Symptomatic with significant shunt (Qp:Qs > 1.5) - LV volume overload - Aortic regurgitation (subaortic VSD) - Prior IE - Pulmonary HTN (early, before Eisenmenger)
Closure Methods - Surgical patch (gold standard) for perimembranous, inlet, outlet - Transcatheter device closure for muscular VSD or post-MI VSD (now expanding indication)
Post-MI VSD - Mechanical complication (Ch273) - Acute, devastating - Emergent surgical or transcatheter repair - IABP, ECMO bridge
288.1.0.1.3 Patent Ductus Arteriosus (PDA)
288.1.0.1.3.1 Embryology
- Fetal: ductus connects pulmonary artery to descending aorta (bypasses fetal lungs)
- Closes within days postnatal (functional) â fibroses (anatomic, weeks-months)
- Failure to close: PDA
- Prematurity, hypoxia, prostaglandins (E2) keep open
288.1.0.1.3.2 Pathophysiology
- LâR shunt at level of great arteries (aorta â pulmonary)
- Continuous âmachineâ murmur
- Variable severity: small to massive
- Untreated â Eisenmenger
- Eisenmenger: reversed shunt â cyanosis of lower body only (RâL below ductus)
288.1.0.1.3.3 Clinical Presentation
- Small PDA: asymptomatic
- Moderate-large: HF, exercise intolerance
- Eisenmenger: cyanosis + clubbing of lower extremities; pink upper body
288.1.0.1.3.4 Examination
- Continuous âmachineryâ murmur at L upper chest, beneath L clavicle
- Wide pulse pressure, bounding pulses
- Eisenmenger PDA: differential cyanosis (cyanotic + clubbed feet, normal arms)
288.1.0.1.3.7 Treatment
Closure Indications - Hemodynamically significant - Prior IE - LV volume overload, PH
Closure Methods - Percutaneous coil / device â first-line for most - Surgical ligation for very large or complex
Pharmacologic Closure (Neonates) - Indomethacin or ibuprofen in premature infants - Definitive in many cases
288.1.0.1.4 Patent Foramen Ovale (PFO)
288.1.0.1.4.1 Background
- 25-30% of adults have PFO (vs ASD = pathologic defect)
- Usually clinically silent
- Small RâL shunt possible during Valsalva
288.1.0.1.4.2 Clinical Significance
- Cryptogenic stroke in young: paradoxical embolism via PFO
- Migraine with aura (debated)
- Decompression sickness in divers
- Platypnea-orthodeoxia syndrome
288.1.0.1.4.3 Diagnosis
- Bubble study (agitated saline) during Valsalva release
- TEE definitive (anatomy, size, atrial septal aneurysm)
288.1.0.1.4.4 PFO Closure for Cryptogenic Stroke
Key Trials: - CLOSURE I (2012) â neg (Starflex device) - PC trial (2013) â neg (Amplatzer) - RESPECT (2013, extended 2017) â PFO closure reduces recurrent stroke - CLOSE (2017) â PFO closure + antiplatelet > antiplatelet alone (especially if atrial septal aneurysm or large shunt) - DEFENSE-PFO (2018) â Korean â confirmed benefit - RESPECT extended (2017) â long-term benefit
Patient Selection (2024 ACC/AHA) - Age < 60 (selected 60-65) - Cryptogenic stroke (CRYPTOGENIC, not from other source) - PFO with paradoxical embolism mechanism (RoPE score) - ASA or NOAC alone vs PFO closure
Procedure: Percutaneous device, ASA + clopidogrel post-procedure
288.1.0.1.5 Atrioventricular Septal Defect (AVSD / Endocardial Cushion)
- AKA âAV canal defectâ
- Failure of endocardial cushion fusion â ostium primum ASD + inlet VSD + common AV valve
- Down syndrome strongly associated (40-50% of T21 with CHD)
- Partial AVSD (ostium primum + cleft MV) vs complete AVSD (large VSD + common AV valve)
- Treatment: surgical repair in infancy
- Adult issues: MR (residual mitral cleft), arrhythmia, HF
288.1.0.1.6 Anomalous Pulmonary Venous Return
- Total Anomalous Pulmonary Venous Return (TAPVR): all 4 pulmonary veins to systemic
- Supracardiac (most common): to L vertical vein â innominate
- Cardiac: to coronary sinus or RA
- Infradiaphragmatic: to portal vein
- Mixed
- Partial Anomalous Pulmonary Venous Return (PAPVR):
- One or more PV â systemic
- Right upper PV to SVC common (often with sinus venosus ASD)
- âScimitar syndromeâ = right PV to IVC + R lung hypoplasia + dextroposition
- Treatment: surgical re-routing in infancy/childhood
288.1.0.2 𩺠åºé鿥
- ASD: secundum most common; fixed split S2; percutaneous closure for secundum
- VSD: perimembranous most common; holosystolic at LLSB; surgical repair preferred
- PDA: continuous âmachineryâ murmur; percutaneous coil
- PFO closure: cryptogenic stroke < 60 yo (CLOSE, RESPECT, DEFENSE-PFO)
- Eisenmenger: absolute contraindication to shunt closure